LOW-DOSE GEMCITABINE IN PROLONGED INFUSION AND CISPLATIN FOR THE TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA

被引：0
|
作者：
Kovac, Vilijem [1 ]
Zwitter, Matjaz [1 ]
Rajer, Mirjana [1 ]
机构：
[1] Inst Oncol Ljubljana, Dept Radiotherapy, Ljubljana, Slovenia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Cisplatin; malignant pleural mesothelioma; Chemotherapy; gemcitabine;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1359 / S1360
页数：2
相关论文
共 50 条
  • [1] A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma
    Kovac, Viljem
    Zwitter, Matjaz
    Rajer, Mirjana
    Marin, Aleksander
    Debeljak, Andrej
    Smrdel, Uros
    Vrankar, Martina
    ANTI-CANCER DRUGS, 2012, 23 (02) : 230 - 238
  • [2] A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma
    Oscar Arrieta
    Diego López-Macías
    Víctor-Osvaldo Mendoza-García
    Ludwing Bacon-Fonseca
    Wendy Muñoz-Montaño
    Eleazar-Omar Macedo-Pérez
    Saé Muñiz-Hernández
    Monika Blake-Cerda
    José-Francisco Corona-Cruz
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 975 - 982
  • [3] A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma
    Arrieta, Oscar
    Lopez-Macias, Diego
    Mendoza-Garcia, Victor-Osvaldo
    Bacon-Fonseca, Ludwing
    Munoz-Montano, Wendy
    Macedo-Perez, Eleazar-Omar
    Muniz-Hernandez, Sae
    Blake-Cerda, Monika
    Corona-Cruz, Jose-Francisco
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 975 - 982
  • [4] Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma
    Arrieta, Oscar
    Munoz-Montano, Wendy
    Muniz-Hernandez, Sae
    Campos, Saul
    Catalan, Rodrigo
    Soto-Molina, Herman
    Guzman Vazquez, Silvia
    Diaz-Alvarez, Osvaldo
    Martinez-Pacheco, Victor
    Turcott, Jenny G.
    Ramos-Ramirez, Maritza
    Cabrera-Miranda, Luis
    Barron, Feliciano
    Cardona, Andres F.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients
    Shukuya, Takehito
    Takahashi, Toshiaki
    Imai, Hisao
    Tokito, Takaaki
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Yamamoto, Nobuyuki
    RESPIRATORY INVESTIGATION, 2014, 52 (02) : 101 - 106
  • [6] Prolonged low-dose infusion for gemcitabine: a systematic review
    Zhao, Dehua
    Chen, Jing
    Chu, Mingming
    Wang, Jisheng
    ONCOTARGETS AND THERAPY, 2019, 12 : 4859 - 4868
  • [7] Divided dose of cisplatin combined with gemcitabine in malignant mesothelioma
    Utkan, Guengoer
    Bueyuekcelik, Abdullah
    Yalcin, Buelent
    Akbulut, Hakan
    Demirkazik, Ahmet
    Dincol, Dilek
    Onur, Handan
    Goeren, Deniz
    Mousa, Umut
    Senler, Filiz Cay
    Icli, Fikri
    LUNG CANCER, 2006, 53 (03) : 367 - 374
  • [8] Primary chemotherapy with low-dose prolonged infusion gemcitabine and cisplatin in patients with bladder cancer: A Phase II trial
    Khaled, Hussein
    Emara, Mohamed E.
    Gaafar, Rabab M.
    Mansour, Osman
    Warith, Ahmed Abdel
    Zaghloul, Mohamed S.
    El Malt, Osama
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (02) : 133 - 136
  • [9] Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma
    Van Haarst J.M.W.
    Baas P.
    Manegold C.
    Schouwink J.H.
    Burgers J.A.
    De Bruin H.G.
    Mooi W.J.
    Van Klaveren R.J.
    De Jonge M.J.A.
    Van Meerbeeck J.P.
    British Journal of Cancer, 2002, 86 (3) : 342 - 345
  • [10] Multicentre phase II study of gemcitabine and cisplatin In malignant pleural mesothelioma
    van Haarst, JMW
    Baas, P
    Manegold, C
    Schouwink, JH
    Burgers, JA
    de Bruin, HG
    Mooi, WJ
    van Klaveren, RJ
    de Jonge, MJA
    van Meerbeeck, JP
    BRITISH JOURNAL OF CANCER, 2002, 86 (03) : 342 - 345
12345